1. Home
  2. AI vs ENOV Comparison

AI vs ENOV Comparison

Compare AI & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C3.ai Inc.

AI

C3.ai Inc.

N/A

Current Price

$8.37

Market Cap

1.5B

Sector

Technology

ML Signal

N/A

Logo Enovis Corporation

ENOV

Enovis Corporation

N/A

Current Price

$24.00

Market Cap

1.6B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
AI
ENOV
Founded
2009
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Fluid Controls
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
AI
ENOV
Price
$8.37
$24.00
Analyst Decision
Hold
Strong Buy
Analyst Count
14
8
Target Price
$20.00
$48.13
AVG Volume (30 Days)
7.1M
1.1M
Earning Date
05-25-2026
06-01-2026
Dividend Yield
N/A
N/A
EPS Growth
4.27
N/A
EPS
N/A
N/A
Revenue
$389,056,000.00
N/A
Revenue This Year
N/A
$9.18
Revenue Next Year
$11.36
$4.69
P/E Ratio
N/A
N/A
Revenue Growth
25.27
N/A
52 Week Low
$9.53
$21.00
52 Week High
$30.24
$40.70

Technical Indicators

Market Signals
Indicator
AI
ENOV
Relative Strength Index (RSI) 28.97 59.42
Support Level N/A $21.30
Resistance Level $14.34 $32.29
Average True Range (ATR) 0.75 1.00
MACD -0.08 0.36
Stochastic Oscillator 13.63 97.82

Price Performance

Historical Comparison
AI
ENOV

About AI C3.ai Inc.

C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications: C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications: and C3 Generative AI, which combines the utility of large language models. Geographically the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

Share on Social Networks: